Rate My Professor Jaime Belkind-Gerson

Belkind-Gerson's research specializations encompass neurogastroenterology, enteric neurogenesis, intestinal motility regulation, gut-brain-microbiome interactions, and innovative treatments for pediatric disorders such as chronic constipation and dyssynergic defecation. Key publications include 'Disorders of gut-brain interaction in children: what is new' (Curr Opin Pediatr, 2025), 'Accuracy and outcomes of endoscopic ultrasound guided anal botulinum toxin injections for pediatric constipation: A pilot study' (J Pediatr Gastroenterol Nutr, 2025), 'Proteolipid protein 1 is involved in the regulation of intestinal motility and barrier function in the mouse' (Am J Physiol Gastrointest Liver Physiol, 2023), 'The Bidirectional Brain-Gut-Microbiome Axis in Pediatrics: What do we know and how may this change our current treatments?' (J Pediatr Gastroenterol Nutr, 2023), and 'Colitis promotes neuronal differentiation of Sox2+ and PLP1+ enteric cells' (Sci Rep, 2017). He has co-authored position papers, such as 'Development of Entrustable Professional Activities and Standards in Training in Pediatric Neurogastroenterology and Motility' (J Pediatr Gastroenterol Nutr, 2021), and participated in symposia like the Advances in Motility and Neurogastroenterology. Awards include the Best Basic Science Neurogastroenterology and Motility Abstract Award from the North American Conference on Gastroparesis and Disorders of Gut-Brain Interaction (2021) and the NASPGHAN Foundation Mid-Level Career Development Award for research on Schwann cell-derived neuro-gliogenesis. His influence extends to clinical protocols, such as timed barium esophagram assessments and pelvic floor therapy for constipation, and leadership in study sections like Digestive and Nutrient Physiology and Diseases. Memberships include the Gates Institute and CCTSI at CU Anschutz.